trimethoprim has been researched along with Impetigo Contagiosa in 2 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mahal, H | 1 |
| Salzberg, R | 1 |
1 trial available for trimethoprim and Impetigo Contagiosa
| Article | Year |
|---|---|
[Comparative clinical and bacteriological studies with Bactrim and ampicillin in the pediatrics].
Topics: Ampicillin; Anti-Infective Agents; Bacterial Infections; Bronchitis; Child, Preschool; Clinical Tria | 1972 |
1 other study available for trimethoprim and Impetigo Contagiosa
| Article | Year |
|---|---|
[Treatment of non specific bacteriologic skin diseases using the bactericidally acting, broad spectrum chemotherapeutic preparation Bactrim Roche].
Topics: Acne Vulgaris; Adult; Anti-Infective Agents; Child; Drug Combinations; Drug Resistance, Microbial; F | 1972 |